Goehringer, N.; Biersack, B.; Peng, Y.; Schobert, R.; Herling, M.; Ma, A.; Nitzsche, B.; Höpfner, M.
Anticancer Activity and Mechanisms of Action of New Chimeric EGFR/HDAC-Inhibitors. Int. J. Mol. Sci. 2021, 22, 8432.
https://doi.org/10.3390/ijms22168432
AMA Style
Goehringer N, Biersack B, Peng Y, Schobert R, Herling M, Ma A, Nitzsche B, Höpfner M.
Anticancer Activity and Mechanisms of Action of New Chimeric EGFR/HDAC-Inhibitors. International Journal of Molecular Sciences. 2021; 22(16):8432.
https://doi.org/10.3390/ijms22168432
Chicago/Turabian Style
Goehringer, Nils, Bernhard Biersack, Yayi Peng, Rainer Schobert, Marco Herling, Andi Ma, Bianca Nitzsche, and Michael Höpfner.
2021. "Anticancer Activity and Mechanisms of Action of New Chimeric EGFR/HDAC-Inhibitors" International Journal of Molecular Sciences 22, no. 16: 8432.
https://doi.org/10.3390/ijms22168432
APA Style
Goehringer, N., Biersack, B., Peng, Y., Schobert, R., Herling, M., Ma, A., Nitzsche, B., & Höpfner, M.
(2021). Anticancer Activity and Mechanisms of Action of New Chimeric EGFR/HDAC-Inhibitors. International Journal of Molecular Sciences, 22(16), 8432.
https://doi.org/10.3390/ijms22168432